Current Seminars

27/01/2015 - 18:30 - Biopartnering Seminar - "Outsourcing in Drug Development: The In Thing To Do"

Guest Speaker: Pete Bastedo, CEO and Co-Founder, Zymewire About the Speaker:  Pete Bastedo is the CEO and co-founder of Zymewire, a software startup developing the first sales support automation (SSA) tool for companies in the life sciences service sector. Under Pete's leadership the company now has a client base ranging from top-five...

20/01/2015 - 18:30 - Biopartnering Seminar - Challenges for GM Crops

Guest Speaker: Mr. Ray Mowling: Consultant within the Biotech Industry and Former President of Monsanto Canada Location: Instructional Centre, Room 120, UTM Campus All welcome! Light refreshments will be served from 6pm to 6:30pm, outside of Room 120 in the Instructional Centre.

13/01/2015 - 18:30 - Biopartnering Seminar

Guest Speaker: Dr. Leigh Revers, Associate Director - Master of Biotechnology, University of Toronto Mississauga About the Speaker:  Dr. Leigh Revers holds an extensive background in biotechnology entrepreneurship, and has more than 15 years of experience working in the life sciences sector, both in academia and industry. Trained...

06/01/2015 - 18:30 - Biopartnering Seminar - Drug Discovery in Academia: Lessons Learned

Guest Speaker: Dr. Patrick Gunning, Assistant Professor of Chemistry, University of Toronto Mississauga About the Speaker:  Most biological processes involve permanent and nonpermanent interactions between different proteins. Many protein complexation events play key roles in various human diseases. The thrust of our research focuses on...

09/12/2014 - 18:30 - Biopartnering Seminar - Increasing Adoption of Kadcyla for Metastatic HER-2 Positive Breast Cancer

Breast cancer is one of the most common cancers amongst women in Canada, with 157,000 women living with breast cancer and an additional 24,400 cases estimated for 2014.  In Canada, 1 in every 30 women will die from stage IV (metastatic) breast cancer. Genotypes of breast cancer play a significant factor when determining tumor aggressiveness...

Pages